By creating “Teflon” versions of natural antibiotics found in frog skin, a research team led by biological chemist E. Neil Marsh has made the potential drugs better at thwarting bacterial defenses, an improvement that could enhance their effectiveness. Marsh will discuss the work Aug. 20 at the 234th national meeting of the American Chemical Society in Boston.
Scientists reported new evidence that infection with a common virus may be a contributing factor to the obesity epidemic sweeping through the United States and other countries.
The B.C. government has invested $100,000 into a BC Lung Association public education campaign that uses the Air Quality Health Index (AQHI) to better inform British Columbians about air pollution levels, Environment Minister Barry Penner said today.
Researchers in Taiwan have demonstrated for the first time that urban air pollution simultaneously affects key indicators of cardiovascular risk in young adults: inflammation, oxidative stress, coagulation and autonomic dysfunction.
Children who are chronically exposed to higher levels of air pollution show marked deficiencies in lung growth and function, and not just short-term breathing problems, according to researchers in Mexico.
Prescribing ambulatory oxygen in patients with chronic obstructive pulmonary disease improves exercise performance, but not the quality of their daily life unless they have resting hypoxemia, according to researchers in Toronto.
Krasniy Oktyabr Inc., located on 60-20th Street, Brooklyn, NY is recalling packages of Herring of the Special Ambassador “7 Uzlov” because the product may be contaminated with Clostridium botulinum, which can cause botulism, a serious and potentially fatal food borne illness.
Individuals who live in a nursing home or take medication to lower blood pressure appear more likely to die during or following hospitalization for heatstroke, according to a study posted online today that will appear in a later print issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Spine surgeon Paul Rubery, M.D., never imagined he would trade in his scalpel for Plaster of Paris, but that?s exactly what he?s planning to do in mid-August, when he learns a new, early treatment casting technique aimed at curing infants stricken with a devastating and aggressive form of scoliosis.
GlaxoSmithKline announced that the U.S. Food and Drug Administration (FDA) has issued a not approvable letter for the supplemental drug application for the 500/50 strength of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) in the treatment of patients with chronic obstructive pulmonary disease (COPD).